As of 9:30 AM on the 12th, Jinwon Life Sciences is trading at 31,150 KRW, down 4.3% from the previous day. This represents a 26.53% decrease compared to September 22. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.

Over the past five days, individual investors have net purchased 89,463 shares, while foreigners and institutions have net sold 19,535 shares and 3,463 shares, respectively.


On October 7, Jinwon Life Sciences became a market topic with the announcement titled "Publication of paper on the mechanism of action of COVID-19 preventive nasal spray, 6.8%...".



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing